ROLE OF
OSTEOPONTIN IN ACUTE AND CHRONIC MOUSE MODELS of ALCOHOLIC LIVER DISEASE
Supervisors
1. Dr Devanshi Seth 2.
A/Prof Paul Haber
Drug Health Services Drug
Health Services
PAGE 5, Building 14, RPAH PAGE
5, Building 14, RPAH
Ph: 9515 7201. Fax:
95158970 Ph:
95157838. Fax: 95158970
Email: Devanshi.seth@email.cs.nsw.gov.au Email: phaber@mail.usyd.edu.au
· Animal
handling: alcohol administration, blood and tissue collection
· Cell
culture
· RNA
and protein isolation, RT-PCR
· Western
blot
· Flow
cytometry
· Immunohistochemistry, ELISA
Brief Overview
Role of inflammation in alcoholic liver disease (ALD):
Inflammation
is a hallmark of alcoholic liver injury and is characterized by intrahepatic infiltration of neutrophils
or mononuclear cells and by altered local and systemic expression of
inflammatory cytokines. It is not clear that inflammation initiates liver
injury, but there is evidence it contributes to the progression of this
disease. Both the innate immune response, induced by the actions of endotoxin, and the adaptive immune response, stimulated by
tissue injury or by neo-antigens derived from alcohol metabolism, contribute to
inflammation and tissue injury. A number of cytokines are prominent in ALD and
these represent potential therapeutic targets.
Osteopontin (OPN) is now recognised as a Th1
cytokine that plays an important role in diverse benign and neoplastic
disease processes. OPN binds to many receptors, including several integrins and CD44. In the liver, OPN expression is
increased in models of chronic liver injury, where it is localised to Kupffer cells, macrophages and stellate
cells. OPN directly mediates hepatic stellate cell
activation in vitro and OPN upregulation
was immediate and preceded evidence of tissue injury in vivo.
In the OPN -/- mouse, liver injury was markedly attenuated with reduced ALT
levels, lobular and portal inflammation, and collagen gene expression.
Recently, three splice variants of OPN have been cloned. To date, the
differential effects of these three splice variants have not been defined in
liver disease. We have shown increased OPN in patients with ALD. Initial
experiments in our laboratory have shown increased OPN in mouse liver as early
as 4 hours after alcohol administration. Interestingly, our preliminary in vitro data (Honours project 2006) in hepatocyte
and stellate cell lines indicated functional differences
between splice variants in cell migration assays.
Hypothesis:
Osteopontin mediates the progression of alcoholic liver injury. Osteopontin promotes hepatic inflammatory cellular
infiltration in response to ethanol.
Plan: We will utilize an acute alcohol
C57BL6 mouse model recently developed by us. The Lieber-DeCarli
model of ethanol administration will be used for the chronic alcohol C57BL6
mouse model. Animals will be match-fed in groups of 4 (wt control, wt
ethanol-acute, wt ethanol-chronic). At the end of the feeding period (8 weeks
for chronic; 4h, 8h, 24h for acute), the animals will be sacrificed, weighed,
and plasma retained for measurement of LFTs (liver
enzymes) and OPN. Plasma OPN would be determined by ELISA. The liver will be
removed, weighed and divided for histology, biochemistry, immunohistochemistry,
frozen samples and for RNA isolation. Histology will be assessed on formalin
fixed, paraffin embedded sections (steatosis, hepatocyte injury and cellular infiltration). mRNA (RT-PCR) and protein (Western, ELISA, immunohistochemistry) levels will be determined for OPN and
its receptors (v3, v5, 91
and41 integrins & CD44).
For analysis of cellular infiltration, CD3 and CD4 markers for Th1 will be
examined by immunohistochemistry and/or flow cytometery analysis to measure the infiltrating cells as
described. Antibodies for these studies are commercially available (
Skills: It is envisaged that the
student who undertakes this project will become proficient in all of these
methods whilst being exposed to a number of other general laboratory
techniques.
Conclusion and Significance: This project
has great significance in determining the nature of the response to ethanol in
liver injury. This project embodies a number of techniques and builds on
established knowledge and expertise with our laboratory.